REQUEST A DEMO
Total
USD $0.00
Search more companies

Seoulin Bio Science Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Seoulin Bio Science Co.,Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Seoulin Bio Science Co.,Ltd. is based in South Korea. The head office is in Seongnam. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on April 01, 1994. The total number of employees is currently 110 (2024). In Q3C2025, the company reported a net sales revenue increase of 2.38%. Over the same period, its total assets grew by 16.08%. The net profit margin of Seoulin Bio Science Co.,Ltd. decreased by 0.89% in 2025.

Headquarters
4Th Floor A Dong Korea Bio Park 694-1 Sampyeong-Dong, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi; Postal Code: 134-030

Contact Details: Purchase the Seoulin Bio Science Co.,Ltd. report to view the information.

Website: http://www.seoulin.co.kr

Basic Information
Total Employees:
Purchase the Seoulin Bio Science Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Seoulin Bio Science Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Seoulin Bio Science Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Seoulin Bio Science Co.,Ltd. report to view the information.
Incorporation Date:
April 01, 1994
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
29.25%
Purchase this report to view the information.
1.38%
Purchase this report to view the information.
1.15%
Subsidiaries
(주)에코트리메디칼
90%
(주)제노자임
58.7%
(주)서린메디케어
51.2%
Company Performance
Financial values in the chart are available after Seoulin Bio Science Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
2.38%
Total Operating Revenue
1.11%
Operating Profit
-46.18%
EBITDA
-47.49%
Net Profit/Loss for the Period
-32.62%
Total Assets
16.08%
Total Equity
1.74%
Operating Profit Margin
-1.11%
Net Profit Margin
-0.89%
Return on Equity (ROE)
-0.58%
Debt / Equity
8.7%
Quick Ratio
-1.35%
Cash Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?